copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer
(Any information to deal,buy, sell, quote for products or service)
Home - Sana Biotechnology Sana is creating engineered cells to repair and control genes in cells or replace missing or damaged cells to solve the underlying causes of disease
Our Science - Sana Biotechnology Sana’s in vivo Cell Engineering platform aims to provide solutions for patients that current gene therapies cannot address Success will require creative science, experienced product and clinical development strategies, and aggregating important technologies
Our Pipeline - Sana Biotechnology Sana is committed to developing safe and effective engineered cells as medicines, which involves evaluation in clinical trials followed by submission of the trial results to regulatory agencies, such as the U S Food and Drug Administration (FDA)
Our Story - Sana Biotechnology Sana was founded with the long view – bringing together great people and the best technologies to deliver on the challenging promise of engineered cells as medicines Three aspirations drive Sana as we look to treat patients with poor outcomes or currently untreatable diseases
For Patients - Sana Biotechnology Sana is a science-driven, patient-centric company filled with employees who wake up everyday focused on advancing potentially curative medicines for people in need
News Releases - Sana Biotechnology, Inc SEATTLE, Aug 26, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at four investor conferences in September
News - Sana Biotechnology Explore news and announcements from Sana Biotechnology to learn more about progress in engineering cells to be medicines
Contact Us - Sana Biotechnology We'd love to hear from you Reach out to learn more about how Sana is working to deliver on the promise of engineering cells to be medicines
Gary Meininger, MD - Sana Biotechnology Prior to joining Sana, Gary served as Senior Vice President and Head of Clinical Development at Vertex Cell and Genetic Therapies (VCGT), where he oversaw all aspects of clinical development for VCGT disease areas, including sickle cell disease, beta-thalassemia, type 1 diabetes, and Duchenne muscular dystrophy